Project Grant RF1AG085589

Award Date 9/17/24
Completion Date 8/31/27
Dollars Obligated $2.4M
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Stanford, CA 94305, USA
Similar Awards
This Project Grant award from the National Institute on Aging (NIA), under the Aging Research program (CFDA 93.866), is supporting research to investigate the role of interleukin-6 (IL-6) trans-signaling in the development of postoperative cognitive decline in aging and Alzheimer's disease. The total award amount is $3,284,161 over the project period from September 15, 2024 to May 31, 2029. The research will be conducted by The Regents of the University of California, San Francisco to address...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to develop effective, scalable tools and interventions to reduce postoperative mortality, delirium, cognitive decline, and other adverse outcomes in vulnerable elderly surgical patients. The 5-year, $801,268 award to the University of Pittsburgh will fund research to create reliable preoperative risk prediction models and enable proactive multimodal perioperative interventions, including...
This $2,497,615 federal Project Grant award, funded by the National Institute on Aging under the Aging Research program (CFDA 93.866), aims to evaluate the impact of new Medicare home health agency (HHA) payment policies on healthcare utilization and outcomes for Medicare beneficiaries with Alzheimer's disease and related dementias (ADRD). The project has three key objectives: 1) characterizing changes in the ADRD beneficiary population eligible for HHA services, 2) evaluating the effect of...
This Project Grant from the National Institutes of Health National Institute on Aging provides $4,489,362 to Duke University from September 15, 2022 through August 31, 2025 under the Aging Research program (CFDA 93.866). The grant will fund research to identify mechanisms of blood-brain barrier dysfunction in delirium superimposed on dementia after surgery. Specifically, the researchers will characterize how the postoperative systemic environment impacts the blood-brain barrier using...
This Project Grant award from the National Institute on Aging (NIA), under CFDA 93.866 Aging Research, provides $715,801 to Duke University to investigate the causal role of blood-brain barrier dysfunction and neuroinflammation in exacerbating postoperative delirium and subsequent onset of Alzheimer's disease and related dementias in aging and hypertension. The overarching goal is to elucidate how hypertension primes the neurovascular unit and worsens delirium-like behavior after orthopedic...
Duke University has been awarded a $4,537,430 Project Grant from the National Institute on Aging, part of the Department of Health and Human Services, to support research under the Aging Research program (CFDA 93.866). The grant will fund a study from September 2022 to August 2025 to examine the role of cellular senescence on postoperative neuroinflammation. Specifically, the researchers will use a mouse model of orthopedic fracture to determine how senescent cell burden exacerbates systemic...
This $334,788 Project Grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) aims to investigate the impact of recent revisions to the Medicare home health payment system (Patient-Driven Groupings Model or PDGM) on access, care delivery, and outcomes for community-living Medicare beneficiaries with Alzheimer's disease and related dementias (ADRD). The 2-year study, starting September 1, 2023, will leverage Medicare claims, home health assessment, and agency data to:...
This Project Grant award from the National Institute on Aging (NIA) under CFDA 93.866 - Aging Research, totaling $3,491,602.00, supports the development of an integrated brain state monitoring system for personalized anesthesia decision support to prevent post-operative delirium in elderly patients and those at risk for Alzheimer's or related dementias. The key products and services to be delivered include: 1) establishing technical feasibility in connecting the monitoring system with electronic...
This Project Grant award of $2,763,221 from the National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), aims to examine the impact of physician, hospital, and skilled-nursing facility factors related to geriatric care on days spent at home among persons with Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). The study, conducted by Cedars-Sinai Medical Center, will use Medicare data linked to other nationally representative...
This $1,933,556 Project Grant awarded by the National Institute on Aging (NIA) under its Aging Research program (CFDA 93.866) will support research to assess the impact of hospital-based health information technology (hospital-HIT) on healthcare quality and equity for patients with Alzheimer's disease and related dementias (ADRD). The primary awardee, the University of Maryland, College Park, will conduct a ten-year longitudinal study to evaluate how hospital-HIT systems that promote care...

This $2,356,117 federal Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) will support research to improve the perioperative management of patients with Alzheimer's disease and related dementias. The primary objectives are to: (1) identify the extent to which surgical patients with these conditions are at increased risk for adverse postoperative outcomes, and (2) estimate the association between various perioperative interventions and the incidence of adverse short-term, medium-term, and long-term surgical outcomes. The research will utilize a novel linked dataset combining healthcare claims data and electronic medical record data to achieve these goals. Key sub-awardees include the University of Michigan, Harvard Medical School, Yale University, and the University of California, San Francisco, who will provide specialized research services and collaborate on this comprehensive study. The award commenced on Sep 17, 2024 and is scheduled for completion by Aug 31, 2027.

Generated 7/1/25, 4:12 AM